Rockwell Medical, Inc.
RMTI
$0.80
-$0.04-4.99%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -25.62% | -43.75% | -37.79% | -16.59% | 11.64% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -25.62% | -43.75% | -37.79% | -16.59% | 11.64% |
| Cost of Revenue | -31.22% | -38.15% | -36.25% | -19.07% | 9.42% |
| Gross Profit | 6.80% | -63.58% | -44.99% | -0.72% | 26.52% |
| SG&A Expenses | 3.06% | -10.39% | -4.54% | 0.73% | 27.70% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -25.57% | -33.62% | -31.19% | -15.53% | 11.24% |
| Operating Income | 23.31% | -181.82% | -361.94% | -2.72% | 5.12% |
| Income Before Tax | 26.72% | -205.35% | -534.99% | 12.48% | 50.00% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 26.72% | -205.35% | -534.99% | 12.48% | 50.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 26.72% | -205.35% | -534.99% | 12.48% | 50.00% |
| EBIT | 23.31% | -181.82% | -361.94% | -2.72% | 5.12% |
| EBITDA | 516.67% | -141.95% | -173.87% | -5.39% | 700.00% |
| EPS Basic | 54.52% | -207.27% | -609.57% | 24.75% | 46.55% |
| Normalized Basic EPS | 31.08% | -195.45% | -571.67% | 21.95% | 57.95% |
| EPS Diluted | 54.82% | -225.00% | -631.91% | 24.75% | 44.01% |
| Normalized Diluted EPS | 31.08% | -198.13% | -596.49% | 21.95% | 57.95% |
| Average Basic Shares Outstanding | 19.85% | 14.18% | 12.67% | 16.30% | 14.75% |
| Average Diluted Shares Outstanding | 19.85% | 11.12% | 7.11% | 16.30% | 14.75% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |